Carregant...
Overexpression of P‐glycoprotein and resistance to Imatinib in chronic myeloid leukemia patients
BACKGROUND: The P‐glycoprotein (P‐gp) is one of the mechanisms of Imatinib (IM) resistance in chronic myeloid leukemia (CML). P‐gp has been identified as an efflux pump involved in releasing of IM outside CML cells. To date, the P‐gp involvement in the IM resistance development was not completely un...
Guardat en:
| Publicat a: | J Clin Lab Anal |
|---|---|
| Autors principals: | , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7521244/ https://ncbi.nlm.nih.gov/pubmed/32715517 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcla.23374 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|